4//SEC Filing
Jansen Burkhard 4
Accession 0001209191-21-023792
CIK 0001651944other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:53 PM ET
Size
8.2 KB
Accession
0001209191-21-023792
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Jansen Burkhard
Chief Medical Officer
Transactions
- Award
Common Stock
2021-03-29+4,897→ 84,991 total - Award
Stock Option (right to buy)
2021-03-29+7,289→ 7,289 totalExercise: $44.48Exp: 2031-03-29→ Common Stock (7,289 underlying)
Footnotes (3)
- [F1]The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the restricted stock units shall vest on March 5, 2022 and (ii) the remaining thirty-six forty-eighths (36/48) shall vest in twelve (12) equal installments of three forty-eighths (3/48) on the fifth day of each third month following March 5, 2022 until the final vesting date on March 5, 2025.
- [F2]Includes 1,057 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2021.
- [F3]Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the shares of issuer common stock exercisable pursuant to this option shall vest on March 29, 2022 and (ii) the remaining thirty-six forty-eighths (36/48) shall vest in thirty-six (36) equal monthly installments of one forty-eighth (1/48) on the twenty-ninth day of each month following March 29, 2022 until the final vesting date on March 29, 2025.
Documents
Issuer
DermTech, Inc.
CIK 0001651944
Entity typeother
Related Parties
1- filerCIK 0001787132
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 4:53 PM ET
- Size
- 8.2 KB